HCI vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HCI presents a compelling value opportunity, trading below both its Intrinsic Value ($159.04) and Graham Number ($202.39). While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, this is offset by an exceptional ROE of 40.46% and a very low Debt/Equity ratio of 0.06. The company is significantly undervalued relative to its sector, with a P/E of 6.84 compared to a sector average of 37.44. Despite a bearish technical trend, the combination of 52.1% revenue growth and consistent earnings beats suggests strong fundamental momentum.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
HCI vs JPM: Head-to-Head Comparison
This page compares HCI Group, Inc. (HCI) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.